SCHEMBL22372364

SCHEMBL22372364

Cc1nc2ccccc2nc1Oc1ccccc1CO

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.47
▸ TSHR P16473 1/20 0.47
▸ KDM4E B2RXH2 7/20 0.43
▸ POLB P06746 1/20 0.42
▸ ALDH1A1 P00352 3/20 0.40
▸ HPGD P15428 1/20 0.40
▸ GLA P06280 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ MAPT P10636 2/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ NPC1 O15118 1/20 0.38
▸ GPR3 P46089 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ SLC6A2 P23975 1/20 0.38
▸ SLC6A4 P31645 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22372361 0.83 KDM4E (0.42) KDM4EALDH1A1HPGDGAAMAPT
SCHEMBL24287258 0.78 ALDH1A1 (0.50) L3MBTL1TSHRKDM4EALDH1A1HPGD
SCHEMBL18796404 0.75 LCK (0.52) L3MBTL1TSHRKDM4EPOLBALDH1A1
SCHEMBL16795314 0.75 ALDH1A1 (0.54) L3MBTL1TSHRKDM4EPOLBALDH1A1
SCHEMBL18796088 0.75 L3MBTL1 (0.47) L3MBTL1TSHRKDM4EPOLBALDH1A1
SCHEMBL22372363 0.74 HTT (0.62) L3MBTL1KDM4EPOLBALDH1A1HPGD
SCHEMBL5950358 0.74 SLC6A2 (0.50) TSHRKDM4ESLC6A2SLC6A4
SCHEMBL24287256 0.72 L3MBTL1 (0.45) L3MBTL1TSHRKDM4EPOLBALDH1A1
SCHEMBL11401433 0.72 L3MBTL1 (0.74) L3MBTL1TSHRKDM4EPOLBHPGD
SCHEMBL5720727 0.71 TSHR (0.70) L3MBTL1TSHRKDM4EPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200275656-A1 TRISUBSTITUTEDSILYLMETHYLPHENOXYQUINOLINES AND ANALOGUES BAYER AKTIENGESELLSCHAFT (DE) 2020-09-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200275656-A1 TRISUBSTITUTEDSILYLMETHYLPHENOXYQUINOLINES AND ANALOGUES PIK3C3, DDT, ERG28 L3MBTL1 1675/4885TSHR 4507/4885KDM4E 203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback